Related Experiment Videos
Management of NSAID-induced ulcer disease
1Krancer Center for Inflammatory Bowel Disease Research, Hahnemann University Philadelphia, Pennsylvania.
American Family Physician
|January 1, 1992
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) increase the risk of gastric ulcers, particularly in high-risk individuals. Prophylactic treatment or discontinuing NSAIDs is recommended for ulcer prevention and healing.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
- NSAID use is linked to significant gastrointestinal risks, including peptic ulcers.
Purpose of the Study:
- To review the risks associated with NSAID use and outline management strategies for gastroduodenal ulcers.
Main Methods:
- Literature review on NSAID-induced gastroduodenal ulcers.
- Analysis of risk factors and prophylactic/therapeutic interventions.
Main Results:
- Patients with prior ulcer disease, smokers, steroid users, and those with comorbidities face higher risks.
- Prophylactic therapy with misoprostol or H2-receptor antagonists is advised for at-risk patients.
- Discontinuation of NSAIDs and standard ulcer treatment are necessary if ulcers develop.
Conclusions:
- NSAID-induced gastroduodenal ulcers pose a considerable risk, especially in vulnerable populations.
- Prophylaxis and prompt management are crucial for mitigating NSAID gastrointestinal toxicity.